Compare SLBT & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SLBT | CGBD |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.9M | 741.7M |
| IPO Year | 2025 | 2013 |
| Metric | SLBT | CGBD |
|---|---|---|
| Price | $0.54 | $10.33 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $12.21 |
| AVG Volume (30 Days) | 46.5K | ★ 389.8K |
| Earning Date | 10-26-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 13.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.45 |
| P/E Ratio | ★ N/A | $37.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.57 | $9.95 |
| 52 Week High | $6.25 | $13.28 |
| Indicator | SLBT | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 22.09 | 36.10 |
| Support Level | N/A | $10.12 |
| Resistance Level | $1.75 | $10.99 |
| Average True Range (ATR) | 0.13 | 0.30 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 4.94 | 0.82 |
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.